Apis Mellifica, Orchitinum, Oophorinum, Petroleum, Platinum Met, Stramonium
Generic Name: apis mellifica, orchitinum, oophorinum, petroleum, platinum met, stramonium
Brand Names:
Emvita 4
Homeopathic Medicine For General Well-being: Too Much Self Control
Overview
Homeopathic Medicine For General Well-being: Too Much Self Control
Uses
Uses: (†) Homeopathic remedy for general well being: too much self control.
Dosage
Directions: (adults & children 6 years & older) Take 12 drops 2 times daily, or as recommended by your health care professional.
Warnings
Warnings: Stop use if symptoms persist or worsen. If you are pregnant or breastfeeding, consult a healthcare professional prior to use. Keep out of reach of children.
Frequently Asked Questions
What is Apis Mellifica, Orchitinum, Oophorinum, Petroleum, Platinum Met, Stramonium used for?▼
Uses: (†) Homeopathic remedy for general well being: too much self control.
What are the important warnings for Apis Mellifica, Orchitinum, Oophorinum, Petroleum, Platinum Met, Stramonium?▼
Warnings: Stop use if symptoms persist or worsen. If you are pregnant or breastfeeding, consult a healthcare professional prior to use. Keep out of reach of children.
Related Medications
Naldemedine
naldemedine
11 DESCRIPTION SYMPROIC (naldemedine), an opioid antagonist, contains naldemedine tosylate as the active ingredient. The chemical name for naldemedine tosylate is: 17-(cyclopropylmethyl)-6,7-didehydro-4,5α-epoxy-3,6,14-trihydroxy-N-[2-(3-phenyl-1,2,4-oxadiazol-5-yl)propan-2-yl]morphinan-7-carboxamide 4-methylbenzenesulfonic acid. The structural formula is: The empirical formula for naldemedine tosylate is C 32 H 34 N 4 O 6 ∙C 7 H 8 O 3 S and the molecular weight is 742.84.
Bilastine (form-2)
bilastine (form-2)
Dosage form: POWDER. Active ingredients: BILASTINE (1 kg/kg). Category: BULK INGREDIENT.
Cosibelimab
cosibelimab
Programmed Death Ligand-1 Blocker [EPC]
11. DESCRIPTION Cosibelimab-ipdl is a human programmed death ligand-1 (PD-L1) blocking antibody. Cosibelimab-ipdl is a human IgG1 lambda monoclonal antibody. Cosibelimab-ipdl is produced in Chinese hamster ovary (CHO) cells and has a calculated molecular weight of approximately 147 kDa. UNLOXCYT (cosibelimab-ipdl) injection for intravenous use is a sterile, preservative-free, clear to opalescent, colorless to yellow or slightly brown solution. It is supplied in single-dose vials.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.